跳至主要内容
临床试验/NCT07755735
NCT07755735已完成不适用

A Study to Evaluate the Effects of a Fiber Supplement on Gut Health

Belli Welli Inc.1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年8月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Change in Overall Gut Health Score

研究概览

简要总结

This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of BelliWelli Daily Fiber + Probiotics supplement on gut health over 12 weeks. One hundred participants with self-reported gut health issues will be randomized to receive either the active fiber supplement or a matched placebo product, taken twice daily.

Participants will complete questionnaires and provide waist and body composition measurements at Baseline, Week 4, Week 8, and Week 12. The primary outcomes include changes in overall gut health scores, waist circumference, and body composition. Secondary outcomes include participant-perceived effects on bloating, regularity, hydration, energy, and hair, skin, and nail support.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be male or female
  • Be aged 18 or older
  • Experiencing issues regarding all of the following over the past 4 weeks: bloating, irregular bowel movements, and self-perceived poor gut health
  • Generally healthy - does not live with any uncontrolled chronic disease
  • Willing to discontinue any other supplements or herbal remedies that target gut or digestive health
  • Not planning on introducing any products or any new forms of prescription medication or supplements that target gut health for the study duration
  • Willing to maintain current diet, sleep pattern, and activity levels for the duration
  • Resides in the United States
  • Not currently partaking in another research study and will not be partaking in any other research study for the next 12 weeks and at any point during this study's duration

排除标准

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries
  • Anyone with any allergies or sensitivities to any of the study product ingredients
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
  • Anyone who is vegan and/or does not consume animal products for any reasons
  • Anyone unwilling to follow the study protocol
  • Anyone with a history of substance abuse

研究组 & 干预措施

Active Supplement

Experimental

干预措施: Active Supplement (Dietary Supplement)

Placebo Comparator

Placebo Comparator

干预措施: Placebo Comparator (Dietary Supplement)

结局指标

主要结局

Change in Overall Gut Health Score

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in GSRS (Gastrointestinal Symptoms Rating Scale) total score from baseline as assessed via self-reported questionnaire

Change in Bowel Movement Quality

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in stool form and consistency as assessed via the Bristol Stool Scale self-reported questionnaire

Change in Self-Reported Hydration

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in self-reported hydration as assessed via self-reported questionnaire

Change in Self-Reported Bloating

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in self-reported bloating as assessed via self-reported questionnaire

Change in Waist Circumference

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in waist circumference from baseline as assessed via tape measure waist measurement

Change in Body Weight

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in body weight from baseline as assessed via Withings Smart Scale

Change in Muscle Mass

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in muscle mass from baseline as assessed via Withings Smart Scale

Change in Fat Mass

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in fat mass from baseline as assessed via Withings Smart Scale

Change in Visceral Fat Mass

时间窗: Baseline, Week 4, Week 8, and Week 12

Mean change in visceral fat mass from baseline as assessed via Withings Smart Scale

次要结局

  • Change in Self-Reported Regularity(Baseline, Week 4, Week 8, and Week 12)
  • Change in Self-Reported Hydration(Baseline, Week 4, Week 8, and Week 12)
  • Change in Self-Reported Stool Feeling(Baseline, Week 4, Week 8, and Week 12)
  • Change in Self-Reported Energy Levels(Baseline, Week 4, Week 8, and Week 12)
  • Change in Self-Reported Hair(Baseline, Week 4, Week 8, and Week 12)
  • Change in Self-Reported Skin(Baseline, Week 4, Week 8, and Week 12)
  • Change in Self-Reported Nail Support(Baseline, Week 4, Week 8, and Week 12)

研究者

发起方
Belli Welli Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验